Center Ventures logo

Center Ventures

Asia, T'ai-pei, Taiwan, Taipei

Description

Center Ventures is a pharmaceutical company.

Investor Profile

Center Ventures has backed more than 2 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 50% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biopharma, Biotechnology, Health Care.
  • Led 1 rounds in the past year.

Stage Focus

  • Series B (50%)
  • Series A (50%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Medical
  • Oncology
  • Pharmaceutical
  • Logistics
  • Public Transportation
  • Transportation
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Center Ventures frequently co-invest with?

Yuanta Financial Holdings Group
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 1
China Universal Asset Management
Asia, Shanghai, China, Shanghai
Co-Investments: 1
GoldTech
Asia, Beijing, China, Beijing
Co-Investments: 1
Cathay Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Chengwei Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 1
99Fund
Asia, Shanghai, China, Shanghai
Co-Investments: 1

What are some of recent deals done by Center Ventures?

Hipot

Wuhan, Hubei, China

Hipot is a technological innovation company dedicated to providing hydrogen fuel cell commercial vehicle transportation solutions.

LogisticsPublic TransportationTransportation
Series AMar 24, 2025
Amount Raised: $62,035,595
TOT BIOPHARM

Suzhou, Jiangsu, China

TOT BIOPHARM is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs.

BiopharmaBiotechnologyHealth CareMedicalOncologyPharmaceutical
Series BAug 8, 2018
Amount Raised: $102,000,000